Dianthus Therapeutics, Inc. /DE/

By person

33 insiders · 116 transactions

11.0×

Marino Garcia holds 11.0 times base salary in stock. $6.97M of shares against $630.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marino Garcia last reported holding, valued at $106.74, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Garcia Marino

CEO AND PRESIDENT

—

$27.96M (12) scheduled

−$27.96M

65,292

0.1167%

$6.97M

—

Savitz Ryan

EVP, CFO & CBO

—

$14.99M (14) scheduled

−$14.99M

0.0000%

$0.00

—

Randhawa Simrat

EVP, Head of R&D

$52.80K (2)

$15.00M (11) scheduled

−$14.95M

4,000

0.0072%

$426.96K

—

Booth Bruce

Director

$10.00M (1)

$254.42K (1)

+$9.75M

1,250,000

2.23%

$133.43M

—

Veness Adam M

SVP, General Counsel and Sec.

—

$4.63M (5) scheduled

−$4.63M

15,000

0.0268%

$1.60M

—

CARR EDWARD

CHIEF ACCOUNTING OFFICER

—

$3.56M (5) scheduled

−$3.56M

0.0000%

$0.00

—

Third Rock Ventures IV, L.P. entity

10% owner

—

$3.06M (2)

−$3.06M

3,058,204

5.47%

$326.43M

+3,061%

Soteropoulos Paula

Director

—

$2.25M (3) scheduled

−$2.25M

0.0000%

$0.00

—

GARDNER JASON

See Remarks

$6.00K (1)

$1.79M (8)

−$1.79M

651,964

1.17%

$69.59M

−3.3%

Fairmount Funds Management LLC entity

Director

$1.40M (5)

—

+$1.40M

0.0000%

$0.00

—

McGeorge Anne

Director

—

$844.82K (5) scheduled

−$844.82K

0.0000%

$0.00

—

COOKE MICHAEL P.

Chief Scientific Officer

—

$654.33K (14)

−$654.33K

240,523

0.4300%

$25.67M

−16.7%

Read Simon

Director

—

$630.79K (7) scheduled

−$630.79K

0.0000%

$0.00

—

DAVIS JOHN C. JR

See Remarks

—

$508.64K (4) scheduled

−$508.64K

8,304

0.0148%

$886.37K

—

ISACSON CHRISTINA K.

Chief Business Officer

—

$316.64K (3)

−$316.64K

83,786

0.1498%

$8.94M

−16.7%

Atlas Venture Fund X, L.P. entity

10% owner

—

$254.42K (1)

−$254.42K

3,148,399

5.63%

$336.06M

+3,154%

ZDRAVESKI ZORAN

See Remarks

—

$193.45K (2)

−$193.45K

128,009

0.2289%

$13.66M

−5.5%

Scadden David

Director

$99.00K (1)

—

+$99.00K

228,175

0.4079%

$24.36M

+17.9%

Deardorf Caren

Chief Commercial Officer

—

$41.98K (1)

−$41.98K

19,762

0.0353%

$2.11M

—

Beetham Thomas W.

See Remarks

—

$41.07K (1)

−$41.07K

19,897

0.0356%

$2.12M

—

Mahoney Stephen F.

See Remarks

—

$38.60K (1)

−$38.60K

17,264

0.0309%

$1.84M

—

Olson Lisa

See Remarks

—

$38.60K (1)

−$38.60K

14,264

0.0255%

$1.52M

—

Stants Kristen

Chief People Officer

—

$38.60K (1)

−$38.60K

20,264

0.0362%

$2.16M

—

Nichols David Wayne

Chief Technical Officer

—

$38.32K (1)

−$38.32K

14,306

0.0256%

$1.53M

—

Byers Blake

Director

—

3,339,137

5.97%

$356.42M

—

GV 2016 GP, L.L.C.

10% owner

—

3,339,137

5.97%

$356.42M

—

Meng Lei

Director

—

2,717,554

4.86%

$290.07M

+123.2%

MOULDER LEON O JR

Director

—

1,436,745

2.57%

$153.36M

+13.1%

RONNEBERG AMY L

Director

—

593,611

1.06%

$63.36M

—

BONNEY MICHAEL W

Director

—

215,346

0.3850%

$22.99M

+11.3%

Daniel Thomas O

Director

—

101,926

0.1822%

$10.88M

+31.7%

Albers Jeffrey W.

Director

—

4,152

0.0074%

$443.18K

—

Borisy Alexis

Director

—

4,100

0.0073%

$437.63K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Randhawa Simrat

1 Sep 2026

EVP, Head of R&D

Sold after exercise

13,309

$106.74

$1.42M

Randhawa Simrat

1 Sep 2026

EVP, Head of R&D

Sold after exercise

7,215

$106.25

$766.59K

Randhawa Simrat

1 Sep 2026

EVP, Head of R&D

Sold after exercise

2,600

$105.19

$273.49K

Read Simon

19 Aug 2026

Director

Sold after exercise

2,778

$117.55

$326.55K

Veness Adam M

10 Aug 2026

SVP, General Counsel and Sec.

Sold after exercise

16,167

$110.38

$1.78M

Read Simon

10 Aug 2026

Director

Sold after exercise

397

$111.77

$44.37K

Read Simon

10 Aug 2026

Director

Sold after exercise

470

$111.05

$52.19K

Read Simon

10 Aug 2026

Director

Sold after exercise

272

$109.96

$29.91K

Read Simon

10 Aug 2026

Director

Sold after exercise

831

$108.95

$90.54K

Read Simon

10 Aug 2026

Director

Sold after exercise

737

$108.17

$79.72K

Read Simon

10 Aug 2026

Director

Sold after exercise

$107.11

$7.50K

McGeorge Anne

10 Aug 2026

Director

Sold after exercise

700

$111.41

$77.99K

McGeorge Anne

10 Aug 2026

Director

Sold after exercise

1,000

$110.64

$110.64K

McGeorge Anne

10 Aug 2026

Director

Sold after exercise

1,800

$109.30

$196.74K

McGeorge Anne

10 Aug 2026

Director

Sold after exercise

2,800

$108.38

$303.46K

McGeorge Anne

10 Aug 2026

Director

Sold after exercise

1,450

$107.58

$155.99K

Garcia Marino

7 Aug 2026

CEO AND PRESIDENT

Sold after exercise

21,909

$108.72

$2.38M

Garcia Marino

7 Aug 2026

CEO AND PRESIDENT

Sold after exercise

104,091

$107.96

$11.24M

Garcia Marino

7 Aug 2026

CEO AND PRESIDENT

Sold after exercise

800

$110.76

$88.61K

Garcia Marino

7 Aug 2026

CEO AND PRESIDENT

Sold after exercise

2,536

$110.02

$279.01K

Garcia Marino

7 Aug 2026

CEO AND PRESIDENT

Sold after exercise

2,373

$109.10

$258.89K

Garcia Marino

7 Aug 2026

CEO AND PRESIDENT

Sold after exercise

23,907

$108.05

$2.58M

Garcia Marino

7 Aug 2026

CEO AND PRESIDENT

Sold after exercise

10,384

$107.49

$1.12M

Veness Adam M

7 Aug 2026

SVP, General Counsel and Sec.

Sold after exercise

616

$111.18

$68.49K

Veness Adam M

7 Aug 2026

SVP, General Counsel and Sec.

Sold after exercise

3,217

$110.61

$355.83K

Savitz Ryan

9 Jul 2026

EVP, CFO & CBO

Sold after exercise

5,566

$101.97

$567.57K

Savitz Ryan

9 Jul 2026

EVP, CFO & CBO

Sold after exercise

15,329

$101.24

$1.55M

Savitz Ryan

9 Jul 2026

EVP, CFO & CBO

Sold after exercise

10,354

$100.22

$1.04M

Veness Adam M

17 Jun 2026

SVP, General Counsel and Sec.

Sold after exercise

13,229

$81.38

$1.08M

Veness Adam M

17 Jun 2026

SVP, General Counsel and Sec.

Sold after exercise

16,771

$80.34

$1.35M

Randhawa Simrat

1 Jun 2026

EVP, Head of R&D

Sold after exercise

4,159

$91.37

$380.01K

Randhawa Simrat

1 Jun 2026

EVP, Head of R&D

Sold after exercise

16,943

$90.72

$1.54M

Randhawa Simrat

1 Jun 2026

EVP, Head of R&D

Sold after exercise

5,428

$89.72

$487.00K

Soteropoulos Paula

8 May 2026

Director

Sold after exercise

599

$85.47

$51.20K

Savitz Ryan

9 Apr 2026

EVP, CFO & CBO

Sold after exercise

8,224

$89.84

$738.84K

Soteropoulos Paula

31 Mar 2026

Director

Sold after exercise

599

$80.11

$47.99K

Savitz Ryan

31 Mar 2026

EVP, CFO & CBO

Sold after exercise

7,232

$85.54

$618.63K

Savitz Ryan

31 Mar 2026

EVP, CFO & CBO

Sold after exercise

19,469

$84.57

$1.65M

Savitz Ryan

31 Mar 2026

EVP, CFO & CBO

Sold after exercise

59,800

$83.90

$5.02M

Savitz Ryan

31 Mar 2026

EVP, CFO & CBO

Sold after exercise

2,366

$82.84

$196.00K

Savitz Ryan

31 Mar 2026

EVP, CFO & CBO

Sold after exercise

800

$81.36

$65.09K

Savitz Ryan

31 Mar 2026

EVP, CFO & CBO

Sold after exercise

1,485

$80.25

$119.17K

Savitz Ryan

31 Mar 2026

EVP, CFO & CBO

Sold after exercise

21,825

$78.86

$1.72M

Savitz Ryan

31 Mar 2026

EVP, CFO & CBO

Sold after exercise

1,390

$78.33

$108.88K

Soteropoulos Paula

24 Mar 2026

Director

Sold after exercise

27,594

$78.05

$2.15M

Randhawa Simrat

12 Mar 2026

EVP, Head of R&D

Sold after exercise

33,830

$81.48

$2.76M

CARR EDWARD

12 Mar 2026

CHIEF ACCOUNTING OFFICER

Sold after exercise

300

$85.53

$25.66K

CARR EDWARD

12 Mar 2026

CHIEF ACCOUNTING OFFICER

Sold after exercise

200

$83.38

$16.68K

CARR EDWARD

12 Mar 2026

CHIEF ACCOUNTING OFFICER

Sold after exercise

3,865

$82.66

$319.48K

CARR EDWARD

12 Mar 2026

CHIEF ACCOUNTING OFFICER

Sold after exercise

23,465

$81.75

$1.92M

CARR EDWARD

12 Mar 2026

CHIEF ACCOUNTING OFFICER

Sold after exercise

15,852

$80.71

$1.28M

Garcia Marino

12 Mar 2026

CEO AND PRESIDENT

Sold after exercise

900

$85.53

$76.98K

Garcia Marino

12 Mar 2026

CEO AND PRESIDENT

Sold after exercise

200

$83.38

$16.68K

Garcia Marino

12 Mar 2026

CEO AND PRESIDENT

Sold after exercise

12,796

$82.60

$1.06M

Garcia Marino

12 Mar 2026

CEO AND PRESIDENT

Sold after exercise

65,517

$81.74

$5.36M

Garcia Marino

12 Mar 2026

CEO AND PRESIDENT

Sold after exercise

43,505

$80.69

$3.51M

Savitz Ryan

4 Dec 2025

CFO & CBO

Sold after exercise

20,000

$45.18

$903.60K

Randhawa Simrat

14 Nov 2025

EVP, Head of R&D

Sold after exercise

109,031

$38.14

$4.16M

Randhawa Simrat

13 Nov 2025

EVP, Head of R&D

Sold after exercise

18,576

$37.72

$700.69K

Randhawa Simrat

13 Nov 2025

EVP, Head of R&D

Sold after exercise

42,765

$37.04

$1.58M

Randhawa Simrat

13 Nov 2025

EVP, Head of R&D

Sold after exercise

26,166

$35.80

$936.74K

Savitz Ryan

9 Sep 2025

CFO & CBO

Sold after exercise

20,000

$35.00

$700.00K

DAVIS JOHN C. JR

2 Jan 2020

Chief Medical Officer

Sold after exercise

11,294

$15.04

$169.82K

DAVIS JOHN C. JR

20 Dec 2019

Chief Medical Officer

Sold after exercise

919

$15.00

$13.79K

DAVIS JOHN C. JR

10 Dec 2019

Chief Medical Officer

Sold after exercise

17,055

$15.00

$255.83K

DAVIS JOHN C. JR

9 Dec 2019

Chief Medical Officer

Sold after exercise

4,614

$15.00

$69.21K

Show all 116 transactions →

Dianthus Therapeutics, Inc. /DE/

By person

Individual transactions

What was left out